1. Home
  2. ABVX vs CBNK Comparison

ABVX vs CBNK Comparison

Compare ABVX & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • CBNK
  • Stock Information
  • Founded
  • ABVX 2013
  • CBNK 1974
  • Country
  • ABVX France
  • CBNK United States
  • Employees
  • ABVX N/A
  • CBNK N/A
  • Industry
  • ABVX
  • CBNK Major Banks
  • Sector
  • ABVX
  • CBNK Finance
  • Exchange
  • ABVX Nasdaq
  • CBNK Nasdaq
  • Market Cap
  • ABVX 511.3M
  • CBNK 471.8M
  • IPO Year
  • ABVX N/A
  • CBNK 2018
  • Fundamental
  • Price
  • ABVX $5.97
  • CBNK $31.46
  • Analyst Decision
  • ABVX Buy
  • CBNK Hold
  • Analyst Count
  • ABVX 4
  • CBNK 1
  • Target Price
  • ABVX $31.50
  • CBNK $35.00
  • AVG Volume (30 Days)
  • ABVX 320.0K
  • CBNK 60.1K
  • Earning Date
  • ABVX 03-24-2025
  • CBNK 07-21-2025
  • Dividend Yield
  • ABVX N/A
  • CBNK 1.27%
  • EPS Growth
  • ABVX N/A
  • CBNK 6.54
  • EPS
  • ABVX N/A
  • CBNK 2.49
  • Revenue
  • ABVX $11,444,012.00
  • CBNK $188,910,000.00
  • Revenue This Year
  • ABVX $284.20
  • CBNK $46.92
  • Revenue Next Year
  • ABVX N/A
  • CBNK $7.82
  • P/E Ratio
  • ABVX N/A
  • CBNK $12.62
  • Revenue Growth
  • ABVX 128.98
  • CBNK 20.92
  • 52 Week Low
  • ABVX $4.77
  • CBNK $19.45
  • 52 Week High
  • ABVX $14.22
  • CBNK $34.31
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 38.44
  • CBNK 48.37
  • Support Level
  • ABVX $5.75
  • CBNK $30.83
  • Resistance Level
  • ABVX $8.57
  • CBNK $32.61
  • Average True Range (ATR)
  • ABVX 0.55
  • CBNK 0.59
  • MACD
  • ABVX -0.17
  • CBNK -0.17
  • Stochastic Oscillator
  • ABVX 7.69
  • CBNK 36.46

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.

Share on Social Networks: